Methylpiperazine

Methylpiperazine

SCHEMBL5742882

CN1CCN(c2ccc([N+](=O)[O-])cc2F)CC1.CN1CCNCC1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.62
LMNA P02545 5/20 0.62
KMT2A Q03164 2/20 0.60
MAPT P10636 3/20 0.56
THRB P10828 1/20 0.56
WDR5 P61964 4/20 0.52
CYP1A2 P05177 2/20 0.51
CYP2D6 P10635 2/20 0.51
CYP2C9 P11712 2/20 0.51
CYP2C19 P33261 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
GAA P10253 1/20 0.51
POLB P06746 1/20 0.50
SIRT6 Q8N6T7 1/20 0.50
HTT P42858 1/20 0.49
MEN1 O00255 1/20 0.49
CYP3A4 P08684 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL854050 0.92 ALDH1A1 (0.71) ALDH1A1LMNAKMT2AMAPTTHRB
SCHEMBL30198175 0.92 ALDH1A1 (0.71) ALDH1A1LMNAKMT2AMAPTTHRB
SCHEMBL29493728 0.89 ALDH1A1 (0.69) ALDH1A1LMNAKMT2AMAPTTHRB
SCHEMBL522009 0.89 ALDH1A1 (0.69) ALDH1A1LMNAKMT2AMAPTTHRB
Hydrochloric Acid SCHEMBL30255520 0.88 ALDH1A1 (0.68) ALDH1A1LMNAKMT2AMAPTTHRB
Hydrochloric Acid SCHEMBL4003615 0.88 ALDH1A1 (0.68) ALDH1A1LMNAKMT2AMAPTTHRB
SCHEMBL861991 0.87 ALDH1A1 (0.64) ALDH1A1LMNAKMT2AMAPTTHRB
SCHEMBL14464189 0.85 ALDH1A1 (0.79) ALDH1A1LMNAKMT2AMAPTTHRB
SCHEMBL6499951 0.84 ALDH1A1 (0.63) ALDH1A1LMNAKMT2AMAPTTHRB
Hydrochloric Acid SCHEMBL3201233 0.83 ALDH1A1 (0.61) ALDH1A1LMNAKMT2AMAPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713484-A2 COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2006-10-25 EP disclosed
WO-2005070891-A2 COMPOUNDS AND METHODS OF USE AMGEN INC (US) 2005-08-04 WO disclosed